Reproductive Health Care for HIV+ Young Women: What Should We Do?
DOI:
https://doi.org/10.55175/cdk.v49i6.247Kata Kunci:
Cervical cancer screening, contraception, HIV, reproductive healthAbstrak
Introduction: This article discusses reproductive health for a young woman with positive HIV during postnatal care. Discussion: In HIV-positive patients, ART treatment protocols may vary. Hormonal contraception in combined oral contraception (COC), progestin-only pill, depo-medroxyprogesterone acetate (DMPA), and implant are considered safe. An intrauterine device (IUD) is also safe for positive HIV women. Cervical cancer screening with Pap smear is performed at the initial diagnosis of HIV in patients less than 30 years of age. Summary: Antiretroviral therapy should be initiated early. HIV patients can safely use either hormonal contraception or an IUD. Cervical cancer screening should be performed at the initial diagnosis of HIV.
Pendahuluan: Artikel ini mendiskusikan kesehatan reproduksi wanita muda HIV positif selama perawatan pasca-melahirkan. Diskusi: Pada pasien positif HIV, protokol terapi antiretrovirus cukup bervariasi. Kontrasepsi hormonal dalam bentuk pil oral kombinasi (POK), pil berbasis progestin, depo-medroxyprogesterone acetate (DMPA), dan implan aman untuk pasien HIV positif. Alat kontrasepsi dalam rahim (AKDR) juga aman untuk perempuan HIV positif. Skrining kanker serviks dengan Pap smear sebaiknya dilakukan saat awal terdiagnosis HIV pada pasien usia <30 tahun. Simpulan: Terapi antiretrovirus sebaiknya dimulai sedini mungkin. Pasien HIV aman menggunakan kontrasepsi hormonal maupun AKDR. Skrining kanker serviks sebaiknya dilakukan saat awal terdiagnosis HIV.
Unduhan
Referensi
MoH. Report of situation analysis of HIVAIDS in 2018. MoH Jakarta; 2018.
UNAIDS. Data Indonesia [Internet]. [cited 2021 Dec 8]. Available from: https://www.unaids.org/en/regionscountries/countries/indonesia
Najmah, Andajani S, Davies SG. Perceptions of and barriers to HIV testing of women in Indonesia. Sex Reprod Health Matters. 2020;28(2):1848003.
Muhaimin T, Besral B. HIV prevalence among pregnant women in eight provincial capitals in Indonesia in 2003-2010. Makara J Health Res. 2012;15(2):93–100.
Lubis DS, Wulandari LPL, Suariyani NLP, Adhi KT, Andajani S. Private midwives’ perceptions on barriers and enabling factors to voluntary counselling and HIV test (VCT) in Bali, Indonesia. Kesmas J Kesehat Masy Nas Natl Public Health J [Internet]. 2019 Aug 1 [cited 2021 Nov 18];14(1). Available from: https://journal.fkm.ui.ac.id/kesmas/article/view/2708
Alliance WR. Respectful maternity care. White Ribb Alliance Wash DC Univers Rights Childbear Women Wash; 2011;
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81.
Del Romero J, Baza MB, Río I, Jerónimo A, Vera M, Hernando V, et al. Natural conception in HIV-serodiscordant couples with the infected partner in suppressive antiretroviral therapy. Medicine (Baltimore). 2016;95(30):4398.
Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: A prospective implementation study in Kenya and Uganda. PLoS Med. 2016;13(8):1002099.
Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61(11):1715–25.
World Health Organization. Sexual and reproductive health of women living with HIV. AIDS [Internet]. 2006. Available from: https://www.refworld.org/pdfid/48abd5960.pdf.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.
Tepper NK. Update to U.S. Medical eligibility criteria for contraceptive use, 2016: Updated recommendations for the use of contraception among women at high risk for HIV infection. MMWR Morb Mortal Wkly Rep [Internet]. 2020 [cited 2021 Nov 18];69. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6914a3.htm
Liu G, Sharma M, Tan N, Barnabas R. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta analysis. AIDS Lond Engl. 2018;32(6):795–808.
Clinical info HIV gov. Human papillomavirus disease. NIH [Internet]. [cited 2021 Nov 18]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-andadolescent-opportunistic-infection/human-papillomavirus-disease
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
